MTOR and non-small cell lung carcinoma: In NSCLC depletion or mutation of multiple genes (PTEN, PI3KCA, RTK, etc.)shall cause dysregulation and overactivation of mammalian target of rapamycin (mTOR), thus promoting tumorigenesis and cancer progression [5, 38].